Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2006 (Vol. 26, No. 5)

Thyroid Disease Manager

URL:www.thyroidmanager.org
  • Good coverage
  • A bit disorganized
Speaking of endocrine disease, it probably doesn't get more pertinent than problems relating to the thyroid. Funded by an "unrestricted educational grant" from Abbott Laboratories, maker of a thyroid medication, Thyroid Disease Manager provides visitors with some tightly organized information in the format of a hyperlinked book. Chapters in the book include everything from basic thyroid physiology to Graves' disease. Other sections of the site cover news, continuing medical education, and an informative (though somewhat disorganized) "Ask an Expert" section that answers submitted questions. Most of these appeared to be from physicians, amazingly enough, suggesting that the advice was definitely expert, to say the least.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »